Table 3.
Characteristics of course registrants in each group |
Differences in characteristics across groups |
||||
---|---|---|---|---|---|
COVID perioda | Comparison groups before COVID period |
Pairwise test of COVID group vs. pre-COVID group |
|||
0–3 months beforeb | 3–6 months beforec | 0–3 months before | 3–6 months before | ||
Demographics | |||||
n | 5442 | 1907 | 5054 | ||
Age M (SD), range | 39.81 (14.66), 12–95 | 37.00 (14.39), 12–88 | 7.78 (13.71), 13–89 | t = −4.13⁎⁎⁎ | t = −2.82⁎⁎ |
Gender (% F) | 80.2% | 75.2% | 78.5% | χ2 = 21.66⁎⁎⁎ | χ2 = 5.15 |
Self-guided % | 94.4% | 88.8% | 93.8% | χ2 = 68.46⁎⁎⁎ | χ2 = 1.64 |
Rural users % | 13.5% | 13.9% | 11.5% | χ2 = 0.20 | χ2 = 9.04⁎⁎ |
Professional recommend % | 22.6% | 41.7% | 19.1% | χ2 = 258.28⁎⁎⁎ | χ2 = 19.53⁎⁎⁎ |
Clinical characteristics | |||||
K10 M (SD), n | 29.60 (8.13), 2332 | 29.79 (7.78), 1489 | 28.61 (7.86), 3671 | t = 0.71 | t = −4.77⁎⁎⁎ |
% K10 > 20 | 86.2% | 86.4% | 82.6% | χ2 = 0.03 | χ2 = 13.68⁎⁎ |
% K10 > 30 | 46.2% | 47.5% | 42.5% | χ2 = 0.62 | χ2 = 7.99⁎⁎⁎ |
PHQ-9 M (SD), n | 13.30 (6.58), 2194 | 13.47 (6.50), 1455 | 12.44 (6.48), 3571 | t = 0.84 | t = −4.81⁎⁎ |
% PHQ-9 > 10 | 63.2% | 64.1% | 58.4% | χ2 = 0.34 | χ2 = 12.69⁎⁎⁎ |
GAD-7 M (SD), n | 11.60 (5.36), 2219 | 11.61 (5.24), 1463 | 10.66 (5.25), 3598 | t = 0.07 | t = −6.58⁎⁎⁎ |
% GAD-7 > 10 | 56.1% | 57.1% | 49.2% | χ2 = 0.39 | χ2 = 26.08⁎⁎⁎ |
Notes. F = female; M = mean; SD = standard deviation; K-10 = Kessler Psychological Distress Scale; PHQ-9 = Patient Health Questionnaire-9; GAD-7 = Generalized Anxiety Disorder 7-item Scale.
During-COVID period = 12th March 2020 to 11th June 2020.
0–3 months before the COVID period = 12th December 2019 to 11th March 2020.
3–6 months before the COVID period = 12th September 2019 to 11th December 2019.
p < .001.
p < .01.